other material
confidence high
sentiment neutral
materiality 0.65
Tempest Therapeutics announces 1-for-13 reverse stock split effective April 8, 2025
Tempest Therapeutics, Inc.
- Reverse stock split at 1:13 ratio, effective 5:00 p.m. ET on April 8, 2025.
- Pre-split shares outstanding: 45,764,184; post-split approx. 3,520,321 shares.
- No fractional shares; cash payments in lieu of fractional shares.
- Trading on Nasdaq Capital Market on split-adjusted basis from April 9, 2025.
- Proportional adjustments to warrants/options exercise prices and shares reserved.